Literature DB >> 11522736

Sacral nerve stimulation as a treatment for fecal incontinence.

H R Rosen1, C Urbarz, B Holzer, G Novi, R Schiessel.   

Abstract

BACKGROUND & AIMS: Sacral nerve stimulation is a proven therapeutic option for the treatment of some forms of urinary incontinence. Very recently, preliminary reports have given evidence for its efficacy in fecal incontinence (FI) too.
METHODS: Since November 1998, 20 patients have been treated for severe FI. The cause of FI was mainly neurologic (n = 15), and was idiopathic in 5 patients. After temporary (subchronic) external stimulation over a period of 10-14 days, patients whose continence status improved underwent implantation of a permanent quadripolar lead and a subcutaneously implanted pulse generator.
RESULTS: Acute (needle) testing revealed a positive pelvic floor response in 16 patients who underwent subsequent permanent implantation. The median number of incontinence episodes decreased from 6 episodes (3-15/21 days) to 2 (0-5/21 days). The time period of retention of a volume of saline causing an urge until definitive defecation was 2 minutes (range, 0-5 minutes) preoperatively and increased to 7.5 minutes (2-15 minutes) postoperatively. Results of preoperative and postoperative (3 months) anal manometry showed a statistically significant increase in maximal resting and squeeze pressures.
CONCLUSIONS: Sacral nerve stimulation seems to be a new and promising modality for patients with certain types of FI in whom conventional treatment options have failed to achieve an improvement.

Entities:  

Mesh:

Year:  2001        PMID: 11522736     DOI: 10.1053/gast.2001.27120

Source DB:  PubMed          Journal:  Gastroenterology        ISSN: 0016-5085            Impact factor:   22.682


  31 in total

1.  Meta-analysis: sacral nerve stimulation versus conservative therapy in the treatment of faecal incontinence.

Authors:  Emile Tan; Nye-Thane Ngo; Ara Darzi; Michael Shenouda; Paris P Tekkis
Journal:  Int J Colorectal Dis       Date:  2011-01-29       Impact factor: 2.571

Review 2.  Novel surgical approaches to fecal incontinence: neurostimulation and artificial anal sphincter.

Authors:  Xiaotuan Zhao; Pankaj J Pasricha
Journal:  Curr Gastroenterol Rep       Date:  2003-10

3.  Electrifying progress for fecal incontinence.

Authors:  Lawrence R Schiller
Journal:  Curr Gastroenterol Rep       Date:  2004-10

4.  Sacral neuromodulation for the treatment of faecal incontinence in a patient with organophosphate poisoning.

Authors:  M Tayyab; R Arsalani-Zadeh; S Ullah; S Mehmood; P Waudby; G S Duthie
Journal:  Tech Coloproctol       Date:  2010-08-04       Impact factor: 3.781

5.  Temporary sacral neuromodulation under local anaesthesia using new anatomical reference points.

Authors:  S Prapasrivorakul; K J Gorissen; M P Gosselink; K Curran; O M Jones; C Cunningham; I Lindsey; R Hompes
Journal:  Tech Coloproctol       Date:  2014-08-24       Impact factor: 3.781

Review 6.  Diagnosis and treatment of pelvic floor disorders: what's new and what to do.

Authors:  William E Whitehead; Adil E Bharucha
Journal:  Gastroenterology       Date:  2010-02-19       Impact factor: 22.682

7.  [PET-CT studies of the support system and continence function of pelvic organs. The pivotal importance of Denonvilliers' fascia for surgical procedures].

Authors:  F Stelzner; H J Biersack; D von Mallek; M Reinhardt
Journal:  Chirurg       Date:  2005-12       Impact factor: 0.955

8.  Sacral nerve stimulation for the treatment of fecal incontinence.

Authors:  Scott A Brill; David A Margolin
Journal:  Clin Colon Rectal Surg       Date:  2005-02

9.  [Fecal incontinence].

Authors:  J Braun; S Willis
Journal:  Chirurg       Date:  2004-09       Impact factor: 0.955

10.  Short-term outcome of percutaneous posterior tibial nerve stimulation (PTNS) for the treatment of faecal incontinence.

Authors:  E Peña Ros; P A Parra Baños; J A Benavides Buleje; J M Muñoz Camarena; C Escamilla Segade; M F Candel Arenas; F M Gonzalez Valverde; A Albarracín Marín-Blázquez
Journal:  Tech Coloproctol       Date:  2016-01       Impact factor: 3.781

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.